ESTRO35 Programme Book

SATURDAY 30 APRIL 2016

08:45 > The axilla- less surgery, more radiotherapy? Speaker: M.I. Algara López (Spain)

SP-0015

09:10 > The internal mammary chain - should we treat it in every node-positive patient? Speaker: P. Poortmans (The Netherlands) 09:35 > Technical approaches to regional lymph node irradiation for breast cancer Speaker: A. Kirby (UK)

SP-0016

SP-0017

Symposium ASSESSMENT ANDMANAGEMENT OF RECTAL MORBIDITY 08:45 - 10:00 | GIALLA

This symposium is dedicated to clarifying the rectal symptoms after radiotherapy to the small pel- vis. Only a few are directly linked to ionizing radiation to the bowel or anal sphincter region. It will be discussed the definition of unique set of pathophysiology to be introduced in the planning of ra- diotherapy. The second topic will aim to distinguish between objective toxicity scoring and subjec- tive patient reported outcomes. Rectal and anal toxicity dose volume histogram and changes will be discriminated. Lastly, the impact and the interest of using rectal spacer to minimized morbidity during irradiation of prostate cancer will be commented.

Chair: P. Maingon (France) Co-Chair: D. Genovesi (Italy)

08:45 > Towards a scoring system built on six distinct radiation-induced illnesses producing late gastrointestinal effects Speaker: G. Steineck (Sweden)

SP-0018

09:10 > Measuring anorectal toxicity and function Speaker: D. Vordermark (Germany)

SP-0019

09:35 > Rectal spacers to minimise morbidity in radiotherapy for prostate cancer Speaker: M. Pinkawa (Germany)

SP-0020

SCIENTIFIC PROGRAMME | PROGRAMME AND EXHIBITION GUIDE

61